Best Pharmaceuticals for Children Act (BPCA) Activities at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Implementation and coordination of the BPCA activities is a major activity for the NICHD’s Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB). The goal of the BPCA Program is to improve pediatric therapeutics through preclinical and clinical drug trials that lead to drug labeling changes.

The OPPTB is also responsible for developing and supporting a comprehensive national research and training effort to increase the knowledge base for treating diseases in pregnant women, infants, and children, using drugs that are appropriately tested within these target populations.

Updates

*NEW: A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms (PDF 474 kb)

The 2012 BPCA Annual Meeting was held on December 4, 2012
Fishers Lane Conference Center
Rockville, MD

Learn about the new Pediatric Formulations Platform initiative funded through an inter-agency agreement between the NICHD and the FDA.

Check out the new FDA Office of Pediatric Therapeutics Web site.